Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEXTROSE\HEPARIN for Pulmonary embolism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where DEXTROSE\HEPARIN was used for Pulmonary embolism.

Most Reported Side Effects for DEXTROSE\HEPARIN

Side Effect Reports % Deaths Hosp.
General physical health deterioration 61 55.5% 61 32
Hyponatraemia 61 55.5% 61 32
Multiple organ dysfunction syndrome 61 55.5% 61 32
Stress 61 55.5% 61 32
Appendicitis 60 54.6% 60 31
Ascites 60 54.6% 60 31
Cardiogenic shock 60 54.6% 60 31
Sepsis 60 54.6% 60 31
Ventricular fibrillation 60 54.6% 60 31
Appendicolith 59 53.6% 59 30
Abdominal pain 58 52.7% 56 33
Abdominal distension 56 50.9% 56 31
Constipation 56 50.9% 56 31
Nausea 56 50.9% 55 31
Vomiting 56 50.9% 55 31

Other Indications for DEXTROSE\HEPARIN

Anticoagulant therapy (55) Intentional product misuse (21) Atrial fibrillation (12) Product used for unknown indication (11) Deep vein thrombosis (9) Off label use (9)

Other Drugs Used for Pulmonary embolism

RIVAROXABAN (11,707) APIXABAN (5,234) WARFARIN (1,552) ENOXAPARIN (1,155) HEPARIN (786) ALTEPLASE (617) DABIGATRAN ETEXILATE (527) DALTEPARIN (431) EDOXABAN (307) XARELTO (284)

Related Pages

DEXTROSE\HEPARIN Full Profile All Pulmonary embolism Drugs DEXTROSE\HEPARIN Demographics DEXTROSE\HEPARIN Timeline